During the past decade, Klinik für Hämatologie, Onkologie, Immunologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinik für Hämatologie, Onkologie, Immunologie" are "COVID-19" (2 trials). Many other conditions were trialed in "Klinik für Hämatologie, Onkologie, Immunologie" in a lesser frequency.

Most popular intervention types in "Klinik für Hämatologie, Onkologie, Immunologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Remdesivir" (2 trials) and "Standard of Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinik für Hämatologie, Onkologie, Immunologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinik für Hämatologie, Onkologie, Immunologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinik für Hämatologie, Onkologie, Immunologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinik für Hämatologie, Onkologie, Immunologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".